These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6128396)

  • 1. The route of administration of imipramine as a factor affecting formation of its metabolite desipramine.
    Daniel W; Adamus A; Melzacka M; Szymura J
    J Pharm Pharmacol; 1982 Oct; 34(10):678-80. PubMed ID: 6128396
    [No Abstract]   [Full Text] [Related]  

  • 2. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats.
    Nagy A
    J Pharm Pharmacol; 1977 Feb; 29(2):104-7. PubMed ID: 15053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of imipramine, desipramine and specific [3H]desipramine binding sites in the rat brain after acute and chronic treatment with imipramine.
    Daniel W; Danek L; Janczar L; Nocon H; Melzacka M
    J Pharm Pharmacol; 1991 Jan; 43(1):31-5. PubMed ID: 1676056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the metabolism of imipramine (Tofanil) in rat brain after single or repeated injections.
    Schneider G; Schneider G
    Ger Med Mon; 1968 Nov; 13(11):543-4. PubMed ID: 5720270
    [No Abstract]   [Full Text] [Related]  

  • 6. On the kinetics of imipramine and related antidepressants.
    Nagy A
    Acta Psychiatr Scand Suppl; 1980; 280():147-56. PubMed ID: 6931475
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1983; 35(2):151-7. PubMed ID: 6622297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of imipramine and desipramine in human breast milk.
    Sovner R; Orsulak PJ
    Am J Psychiatry; 1979 Apr; 136(4A):451-2. PubMed ID: 426114
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W; Adamus A; Melzacka M; Szymura J; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine.
    Daniel W; Melzacka M
    J Pharm Pharmacol; 1992 May; 44(5):429-32. PubMed ID: 1359059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic correlation between in vitro hepatic microsomal enzyme kinetics and in vivo metabolism of imipramine and desipramine in rats.
    Chiba M; Fujita S; Suzuki T
    J Pharm Sci; 1990 Apr; 79(4):281-7. PubMed ID: 2352136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.
    Chiba M; Fujita S; Suzuki T
    Biochem Pharmacol; 1990 Jan; 39(2):367-72. PubMed ID: 2302258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine and desipramine disposition in the elderly.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution and elimination kinetics of imipramine in rat brain after a single intraperitoneal administration.
    Masada M; Suzuki K; Kikuta S; Yamashita S; Nakanishi K; Nadai T; Igarashi Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1986 May; 34(5):2173-7. PubMed ID: 3742657
    [No Abstract]   [Full Text] [Related]  

  • 16. First-pass metabolism of imipramine in man.
    Gram LF; Christiansen J
    Clin Pharmacol Ther; 1975 May; 17(5):555-63. PubMed ID: 1126113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics of imipramine-N-oxide in rats.
    Nagy A
    Acta Pharmacol Toxicol (Copenh); 1978 Jan; 42(1):68-72. PubMed ID: 579713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage.
    Melzacka M; Rurak A; Danek L; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(4):525-32. PubMed ID: 4080646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental imipramine and desipramine poisoning in the rat.
    Rauws AG; Olling M
    Arch Toxicol; 1976 Mar; 35(2):97-106. PubMed ID: 947318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.